We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 329

Increased spotlight on emergency department facility coding by CMS, HHS and DOJ

  • Duane Morris LLP
  • -
  • USA
  • -
  • May 16 2013

Although the professional component of coding for evaluation and management services ("E&M Services") has been scrutinized over the years, until

Back to the future for damages in California, future damages must relate back to past paid (not billed) medical charges

  • Duane Morris LLP
  • -
  • USA
  • -
  • May 9 2013

In Corenbaum v. Lampkin, --- Cal.Rptr.3d ----, 2013 WL 1801996 (Cal.App. 2 Dist.), the court made it clear that when calculating damages in a

Attention mHealth, HIT and telemedicine app developers: privacy and security by design is critical

  • Duane Morris LLP
  • -
  • USA
  • -
  • May 3 2013

Mobile health ("mHealth") medical app developers, including health information technology ("HIT") and telemedicine app developers, tend to focus on

Congress drafts compounding legislation -- defines compounded drugs as new drugs under the FFDCA and creates bright line between traditional compounders and compounding manufacturers

  • Duane Morris LLP
  • -
  • USA
  • -
  • April 29 2013

In the wake of the New England Compounding Center meningitis outbreak, the federal government has actively pushed for greater legislative oversight

HIPAA marketing and sale provisions: legal potholes for providers, payors, advertisers, data aggregators, market researchers and others

  • Duane Morris LLP
  • -
  • USA
  • -
  • April 19 2013

The privacy and security standards under the Health Insurance Portability and Accountability Act of 1996 ("HIPAA") and its regulations (the "HIPAA

Compounding animal drugs from bulk ingredients

  • Duane Morris LLP
  • -
  • USA
  • -
  • April 17 2013

Recent public discussion about the federal role in regulating compounding pharmacies has focused on compounded drugs for human use. Compounded

Landmark ruling expands OFCCP subcontractor coverage to healthcare providers

  • Duane Morris LLP
  • -
  • USA
  • -
  • April 3 2013

The U.S. District Court for the D.C. Circuit has ruled in UPMC Braddock v. Harris that three hospitals affiliated with the University of Pittsburgh

Increased government scrutiny of physician-owned device distributorships

  • Duane Morris LLP
  • -
  • USA
  • -
  • April 3 2013

On March 26, 2013, the Office of Inspector General of the U.S. Department of Health and Human Services (OIG) increased its scrutiny of and pressure

Virginia enacts the first state law regulating interchangeable biosimilar products

  • Duane Morris LLP
  • -
  • USA
  • -
  • March 28 2013

On March 16, 2013, Virginia became the first state to enact legislation regulating a pharmacist's substitution of an interchangeable biologic drug

Long-term care and Medicaid managed care initiatives in Illinois

  • Duane Morris LLP
  • -
  • USA
  • -
  • March 25 2013

Currently, Illinois has three Medicaid managed care programs: Primary Care Case Management; Voluntary Managed Care; and the Integrated Care Program